UBS AG has announced the launch of its new Trigger Autocallable Contingent Yield Notes linked to the common stock of Tesla, Inc. The pricing supplement, filed on October 29, 2026, outlines the terms and conditions of this investment product, which is designed to offer investors a contingent coupon based on the performance of Tesla's stock.
This offering is significant as it showcases UBS's strategy to expand its investment product offerings within the National Commercial Banks sector. The notes are structured to provide potential returns while also carrying substantial risks, including the possibility of losing the principal amount invested.
About UBS AG
UBS AG, incorporated in Switzerland, operates primarily in the financial services industry, specifically classified under National Commercial Banks (SIC 6021). The company is publicly traded on the New York Stock Exchange under several tickers, including AMUB and BDCX. UBS is known for its wealth management, investment banking, and asset management services.
What the Filing Says
The filing details that the notes are unsubordinated and unsecured debt obligations issued by UBS AG. They are linked to Tesla's common stock and will pay a contingent coupon only if the stock's closing level meets certain criteria on specified observation dates. If the stock does not meet these criteria, no coupon will be paid, and investors may face a loss of principal if the stock underperforms.
"Investing in the Notes involves significant risks. You may lose a significant portion or all of your initial investment..."
Impact
This offering may affect a wide range of investors, particularly those interested in high-risk, high-reward investment products. The notes are geared towards investors who are comfortable with the volatility of the stock market and the associated risks of investing in securities linked to individual stocks.
What's Next
Details regarding the next steps following this filing were not provided. Investors interested in the notes should monitor UBS's future filings for updates and additional information.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










